Collectively, these findings suggested that oncogenic circ_0007534 facilitates EMT, invasion, and Paclitaxel resistance in endometrial cancer through the miR-625/ZEB2 pathway (Figure 10). This evidence concerns the gene ZEB2 and endometrial cancer.